LOH on 10p14-p15 targets the PFKFB3 gene locus in human glioblastomas

Genes Chromosomes and Cancer

Volumn 50, Issue 12, 2011, Pages 1010-1020

  Fleischer, Michael ^a   Kessler, Renate ^a   Klammer, Angelika ^b   Warnke, Jan Peter ^b   Eschrich, Klaus ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b Paracelsus Hospital   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

KRUPPEL LIKE FACTOR 6; MESSENGER RNA; TUMOR SUPPRESSOR PROTEIN;

ADULT; ARTICLE; CHROMOSOME ARM; CLINICAL ARTICLE; CONTROLLED STUDY; DNA ISOLATION; FEMALE; GENE EXPRESSION; GENE LOCUS; GENE MAPPING; GENE TARGETING; GLIOBLASTOMA; GROWTH INHIBITION; HETEROZYGOSITY LOSS; HUMAN; MALE; MICROSATELLITE MARKER; PALATOPLASTY; PFKFB3 GENE LOCU; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROTEIN ISOLATION; RNA ISOLATION;

ADULT; AGED; AGED, 80 AND OVER; ALLELES; BRAIN NEOPLASMS; CHROMOSOMES, HUMAN, PAIR 10; FEMALE; GENES, TUMOR SUPPRESSOR; GLIOBLASTOMA; HUMANS; KRUPPEL-LIKE TRANSCRIPTION FACTORS; LOSS OF HETEROZYGOSITY; MALE; MICROSATELLITE REPEATS; MIDDLE AGED; PHOSPHOFRUCTOKINASE-2; PROGNOSIS; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER; TUMOR SUPPRESSOR PROTEINS; YOUNG ADULT;

EID: 80053642763     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20914     Document Type: Article

References (43)

1. Atsumi T, Chesney J, Metz C, Leng L, Donnelly S, Makita Z, Mitchell R, Bucala R. 2002. High expression of inducible 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase (iPFK-2; PFKFB3) in human cancers. Cancer Res 62: 5881-5887.
2. Balss J, Meyer J, Mueller W, Korshunov A, Hartmann C, von Deimling A. 2008. Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathol 116: 597-602.
3. Calvo MN, Bartrons R, Castaño E, Perales JC, Navarro-Sabaté A, Manzano A. 2006. PFKFB3 gene silencing decreases glycolysis, induces cell-cycle delay and inhibits anchorage-independent growth in HeLa cells. FEBS Lett 580: 3308-3314.
4. Camacho-Vanegas O, Narla G, Teixeira MS, DiFeo A, Misra A, Singh G, Chan AM, Friedman SL, Feuerstein BG, Martignetti JA. 2007. Functional inactivation of the KLF6 tumor suppressor gene by loss of heterozygosity and increased alternative splicing in glioblastoma. J Int Cancer 121: 1390-1395.
5. Chesney J, Mitchell R, Benigni F, Bacher M, Spiegel L, Al-Abed Y, Han JH, Metz C, Bucala R. 1999. An inducible gene product for 6-phosphofructo-2-kinase with an AU-rich instability element: Role in tumor cell glycolysis and the Warburg effect. Proc Natl Acad Sci USA 96: 3047-3052.
6. Di Chiro G, DeLaPaz RL, Brooks RA, Sokoloff L, Kornblith PL, Smith BH, Patronas NJ, Kufta CV, Kessler RM, Johnston GS, Manning RG, Wolf AP. 1982. Glucose utilization of cerebral gliomas measured by [18F] fluorodeoxyglucose and positron emission tomography. Neurology 32: 1323-1329.
7. Fujisawa H, Reis RM, Nakamura M, Colella S, Yonekawa Y, Kleihues P, Ohgaki H. 2000. Loss of heterozygosity on chromosome 10 is more extensive in primary (de novo) than in secondary glioblastomas. Lab Invest 80: 65-72.
8. Hata N, Yoshimoto K, Yokoyama N, Mizoguchi M, Shono T, Guan Y, Tahira T, Kukita Y, Higasa K, Nagata S, Iwaki T, Sasaki T, Hayashi K. 2006. Allelic losses of chromosome 10 in glioma tissues detected by quantitative single-strand conformation polymorphism analysis. Clin Chem 52: 370-378.
9. Homma T, Fukushima T, Vaccarella S, Yonekawa Y, Di Patre PL, Franceschi S, Ohgaki H. 2006. Correlation among pathology, genotype, and patient outcomes in glioblastoma. J Neuropathol Exp Neurol 65: 846-854.
10. Howe FA, Barton SJ, Cudlip SA, Stubbs M, Saunders DE, Murphy M, Wilkins P, Opstad KS, Doyle VL, McLean MA, Bell BA, Griffiths JR. 2003. Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med 49: 223-232.
11. Ichimura K, Schmidt EE, Miyakawa A, Goike HM, Collins VP. 1998. Distinct patterns of deletion on 10p and 10q suggest involvement of multiple tumor suppressor genes in the development of astrocytic gliomas of different malignancy grades. Genes Chromosomes Cancer 22: 9-15.
12. Jeng Y-M, Hsu H-C. 2003. KLF6, a putative tumor suppressor gene, is mutated in astrocytic gliomas. Int J Cancer 105: 625-629.
13. Kessler R, Eschrich K. 2001. Splice isoforms of ubiquitous 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase in human brain. Brain Res Mol Brain Res 87: 190-195.
14. Kessler R, Bleichert F, Warnke J-P, Eschrich K. 2008. 6-Phosphofructo-2-kinase/fructose-2, 6-bisphosphatase (PFKFB3) is up-regulated in high-grade astrocytomas. J Neurooncol 86: 257-264.
15. Kimmelman AC, Ross DA, Liang BC. 1996. Loss of heterozygosity of chromosome 10p in human gliomas. Genomics 34: 250-254.
16. Kon H, Sonoda Y, Kumabe T, Yoshimoto T, Sekiya T, Murakami Y. 1998. Structural and functional evidence for the presence of tumor suppressor genes on the short arm of chromosome 10 in human gliomas. Oncogene 16: 257-263.
17. Louis DN, Ohgaki H, Wiestler OD, Cavenee WK, Burger PC, Jouvet A, Scheithauer BW, Kleihues P. 2007. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 114: 97-109.
18. Mahlknecht U, Chesney J, Hoelzer D, Bucala R. 2003. Cloning and chromosomal characterization of the 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase-3 gene (PFKFB3, iPFK2). Int J Oncol 23: 883-891.
19. Manzano A, Rosa JL, Ventura F, Pérez JX, Nadal M, Estivill X, Ambrosio S, Gil J, Bartrons R. 1998. Molecular cloning, expression, and chromosomal localization of a ubiquitously expressed human 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase gene (PFKFB3). Cytogenet Cell Genet 83: 214-217.
20. Minchenko OH, Opentanova I, Caro J. 2003. Hypoxic regulation of the 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase gene family (PFKFB-1-4) expression in vivo. FEBS Lett 554: 264-270.
21. Minchenko OH, Ogura T, Opentanova IL, Minchenko DO, Esumi H. 2005. Splice isoform of 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase-4: Expression and hypoxic regulation. Mol Cell Biochem 280: 227-234.
22. Montanini L, Bissola L, Finocchiaro G. 2004. KLF6 is not the major target of chromosome 10p losses in glioblastomas. Int J Cancer 111: 640-641.
23. Narla G, Heath KE, Reeves HL, Li D, Giono LE, Kimmelman AC, Glucksman MJ, Narla J, Eng FJ, Chan AM, Ferrari AC, Martignetti JA, Friedman SL. 2001. KLF6, a candidate tumor suppressor gene mutated in prostate cancer. Science 294: 2563-2566.
24. Ohgaki H, Kleihues P. 2005. Epidemiology and etiology of gliomas. Acta Neuropathol 109: 93-108.
25. Ohgaki H, Kleihues P. 2007. Genetic pathways to primary and secondary glioblastoma. Am J Pathol 170: 1445-1453.
26. Ohgaki H, Kleihues P. 2009. Genetic alterations and signaling pathways in the evolution of gliomas. Cancer Sci 100: 2235-2241.
27. Ohgaki H, Dessen P, Jourde B, Horstmann S, Nishikawa T, Di Patre PL, Burkhard C, Schuler D, Probst-Hensch NM, Maiorka PC, Baeza N, Pisani P, Yonekawa Y, Yasargil MG, Lutolf UM, Kleihues P. 2004. Genetic pathways to glioblastoma: A population-based study. Cancer Res 64: 6892-6899.
28. Okar DA, Manzano A, Navarro-Sabate A, Riera L, Bartrons R, Lange AJ. 2001. PFK-2/FBPase-2: Maker and breaker of the essential biofactor fructose-2, 6-bisphosphate. Trends Biochem Sci 26: 30-35.
29. Parsons DW, Jones S, Zhang X, Lin JC, Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, Olivi A, McLendon R, Rasheed BA, Keir S, Nikolskaya T, Nikolsky Y, Busam DA, Tekleab H, Diaz LA, Jr, Hartigan J, Smith DR, Strausberg RL, Marie SK, Shinjo SM, Yan H, Riggins GJ, Bigner DD, Karchin R, Papadopoulos N, Parmigiani G, Vogelstein B, Velculescu VE, Kinzler KW. 2008. An integrated genomic analysis of human glioblastoma multiforme. Science 321: 1807-1812.
30. Rasheed BK, McLendon RE, Friedman HS, Friedman AH, Fuchs HE, Bigner DD, Bigner SH. 1995. Chromosome 10 deletion mapping in human gliomas: A common deletion region in 10q25. Oncogene 10: 2243-2246.
31. Rider MH, Bertrand L, Vertommen D, Michels PA, Rousseau GG, Hue L. 2004. 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatase: Head-to-head with a bifunctional enzyme that controls glycolysis. Biochem J 381: 561-579.
32. Riemenschneider MJ. 2009. Molecular neuropathology of gliomas. Int J Mol Sci 10: 184-212.
33. Riemenschneider MJ, Reifenberger G. 2009. Novel insights into the pathogenesis of gliomas based on large-scale molecular profiling approaches. Curr Opin Neurol 22: 619-624.
34. Schmidt MC, Antweiler S, Urban N, Mueller W, Kuklik A, Meyer-Puttlitz B, Wiestler OD, Louis DN, Fimmers R, von Deimling A. 2002. Impact of genotype and morphology on the prognosis of glioblastoma. J Neuropathol Exp Neurol 61: 321-328.
35. Tada K, Shiraishi S, Kamiryo T, Nakamura H, Hirano H, Kuratsu J, Kochi M, Saya H, Ushio Y. 2001. Analysis of loss of heterozygosity on chromosome 10 in patients with malignant astrocytic tumors: Correlation with patient age and survival. J Neurosurg 95: 651-659.
36. Van Schaftingen E, Jett MF, Hue L, Hers HG. 1981. Control of liver 6-phosphofructokinase by fructose 2, 6-bisphosphate and other effectors. Proc Natl Acad Sci USA 78: 3483-3486.
37. Voesten AM, Bijleveld EH, Westerveld A, Hulsebos TJ. 1997. Fine mapping of a region of common deletion on chromosome arm 10p in human glioma. Genes Chromosomes Cancer 20: 167-172.
38. Wager M, Menei P, Guilhot J, Levillain P, Michalak S, Bataille B, Blanc JL, Lapierre F, Rigoard P, Milin S, Duthe F, Bonneau D, Larsen CJ, Karayan-Tapon L. 2008. Prognostic molecular markers with no impact on decision-making: The paradox of gliomas based on a prospective study. Br J Cancer 98: 1830-1838.
39. Warburg O. 1956. On the origin of cancer cells. Science 123: 309-314.
40. Watanabe F, Furuya E. 1999. Tissue-specific alternative splicing of rat brain fructose 6-phosphate 2-kinase/fructose 2, 6-bisphosphatase. FEBS Lett 458: 304-308.
41. Yalcin A, Telang S, Clem B, Chesney J. 2009a. Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2, 6-bisphosphatases in cancer. Exp Mol Pathol 86: 174-179.
42. Yalcin A, Clem BF, Simmons A, Lane A, Nelson K, Clem AL, Brock E, Siow D, Wattenberg B, Telang S, Chesney J. 2009b. Nuclear targeting of 6-phosphofructo-2-kinase (PFKFB3) increases proliferation via cyclin-dependent kinases. J Biol Chem 284: 24223-24232.
43. Zscharnack K, Kessler R, Bleichert F, Warnke JP, Eschrich K. 2009. The PFKFB3 splice variant UBI2K4 is downregulated in high-grade astrocytomas and impedes the growth of U87 glioblastoma cells. Neuropathol Appl Neurobiol 35: 566-578.